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ABSTRACT 27 
 28 
In this work, we describe the characterization of a quantity-limited sample (100ng) of yeast 29 
mitochondria by shotgun bottom-up proteomics. Sample characterization was carried out by 30 
sheathless capillary electrophoresis, equipped with a high sensitivity porous tip and coupled to 31 
tandem mass spectrometry (CESI-MS/MS) and concomitantly with a state-of-art nano flow 32 
liquid chromatography coupled to a similar mass spectrometry (MS) system (nanoLC-33 
MS/MS). With single injections, both nanoLC-MS/MS and CESI-MS/MS 60 min-long 34 
separation experiments allowed to identify 271 proteins (976 unique peptides)  and 300 35 
proteins (1765 unique peptides) respectively, demonstrating a significant specificity and 36 
complementarity in identification depending on the physicochemical separation employed. 37 
Such complementary, maximizing the number of analytes detected, presents a powerful tool 38 
to deepen a biological sample's proteomic characterization. A comprehensive study of the 39 
specificity provided by each separating technique was also performed using the different 40 
properties of the identified peptides: molecular weight (MW), mass-to-charge ratio (m/z), 41 
isoelectric point (pI), sequence coverage or MS/MS spectral quality enabled to determine the 42 
contribution of each separation. For example, CESI-MS/MS enables to identify larger 43 
peptides and eases the detection of those having extreme pI without impairing spectral 44 
quality. The addition of peptides, and therefore proteins identified by both techniques allowed 45 
to increase significantly the sequence coverages and then the confidence of characterization. 46 
In this study, we also demonstrated that the 2 yeast enolase isoenzymes were both 47 
characterized in the CESI-MS/MS dataset. The observation of discriminant proteotypic 48 
peptides is facilitated when a high number of precursors with high-quality MS/MS spectra are 49 
generated.  50 
 51 
 52 
 53 
 54 
 55 
 56 
 57 
 58 
Introduction 59 
 60 
In recent years, mass spectrometry-based proteomics was recognized as one of the best 61 
tools for identifying proteins with new functions, mapping their interactions in a cellular 62 
context and discovering new biomarkers for medical research 1. In order to maximize the 63 
number of analytes successfully ionized, detected and identified in mass spectrometry (MS), a 64 
physicochemical separation prior to MS analysis is often applied. Currently, liquid 65 
chromatography (LC) is the most widely used separation techniques that can be coupled on-66 
line with a mass spectrometer 2. In a classical nanoLC coupled to tandem mass spectrometry 67 
(nanoLC-MS/MS) experiment, which is the most usual method for proteomic application, 68 
analytes are eluted from a reverse-phase column by increasing the organic content of the 69 
mobile phase to separate peptides by hydrophobicity. Capillary Zone Electrophoresis (CZE) is 70 
another separating technique that has been successfully coupled to electrospray ionization 3: 71 
with the use of an electrical field, ions are separated based on their electrophoretic mobility 72 
which is dependent upon the charge of the molecule and the analyte’s hydrodynamic radius 4. 73 
Capillary electrophoresis (CE) is gaining more and more interest mostly because of recent 74 
technical improvements regarding capillary zone electrophoresis–mass spectrometry (CZE-75 
MS) coupling that allow the use of lower flow rates resulting in improved sensitivity 5,6 and 76 
also because ion suppression phenomenon is largely reduced compared to a nanoLC-MS 77 
analysis 7-9. Recently, CE–MS has emerged as a highly efficient separation technique 10 and is 78 
considered as a powerful technique for the analysis of peptides and proteins 4,11-22.  79 
Taking into considerations these observations, an ideal workflow would be the 80 
combination of orthogonal separative techniques based on different physiochemical 81 
principles. Indeed, as a significant fraction of proteins can escape detection in individual 82 
separation approaches 23, crossing over different techniques and their respective benefits 83 
would minimize that problem. Consecutive CZE-MS/MS and nanoLC-MS/MS analysis 84 
campaigns can be easily imagined on the same samples as further discussed in this study with 85 
the example of a quantity-limited sample from a yeast mitochondrial extract.  86 
In this study, we used CZE-MS/MS as well as a classical nanoLC configuration to 87 
explore the S. cerevisiae mitochondrial proteome. CZE-MS/MS experiments were performed 88 
using a recently introduced CE-MS interface referred as CESI-MS. New instrumental 89 
approaches are often developed and validated on model systems such as the baker’s yeast 90 
Saccharomyces cerevisiae, mainly because many essential processes are conserved between 91 
yeast and other organisms of interest like humans 24. Numerous benefits derive from the fact 92 
that yeast is one of the simplest eukaryotes 25. Because of its importance in molecular biology, 93 
it was the first eukaryotic organism for which the genome sequence was completed 26. 94 
Mitochondrion is a complex intracellular organelle, crucial for numerous cellular functions 95 
like normal cell metabolism 27, cellular energetic 28, maintenance of ion homeostasis 29 and 96 
programmed cell death 30,31. To achieve the best results, a highly purified mitochondrial 97 
preparation is mandatory 32,33. To understand the role of this complex organelle especially in 98 
disease, it is important to extensively characterize its protein composition: identifying the 99 
whole set of resident proteins within a complex organelle remains a major challenge in cell 100 
biology even if innovative technologies are emerging year after year. Previous proteomic 101 
analyses on purified mitochondria resulted in a repertoire of 1000 to 1500 different proteins 102 
for that organelle, in either yeast or human samples 34,35.  103 
In the current work, the aim is to demonstrate the improvement in protein identification 104 
by shotgun bottom-up proteomics of mitochondria extract from Saccharomyces cerevisiae by 105 
using two different physicochemical separations prior to the MS analysis. The study is carried 106 
out on a limited quantity (100ng) of sample, roughly representing 1000 proteins. 107 
Identifications obtained by CESI-MS/MS were compared to those achieved in nanoLC-108 
MS/MS. Specificity of each separating technique was determined observing different 109 
physicochemical properties of the identified peptides: molecular weight (MW), mass-to-110 
charge ratio (m/z), isoelectric point (pI), sequence coverage as well as MS/MS spectral 111 
quality. Moreover, a cellular localization analysis of all identified proteins was also 112 
performed.  Biological significance was finally investigated by comparing the protein 113 
identifications from this study to previously published studies. In addition, emphasis was 114 
placed onto a challenging area of proteomics research which is isoforms characterization. 115 
Taking together, the results presented in this study allowed us to assess the gain of 116 
information which can be achieved by two complementary and orthogonal techniques, in 117 
terms of peptide metrics, sequence coverage, spectrum quality and isoforms characterization. 118 
 119 
Experimental 120 
Materials and reagents. 121 
Chemicals used were of analytical grade or high purity grade and purchased from Sigma-122 
Aldrich (Saint Louis, MO, USA).Water used to prepare buffers, mobile phases and sample 123 
solutions was obtained using an ELGA purelab UHQ PS water purification system (Bucks, 124 
UK). Dithiothreitol (DTT) and iodoacetamide (IAA) were purchased from Sigma (St. Louis, 125 
MO, USA). Trypsin sequencing grade was obtained from Promega (Madison, WI USA). All 126 
other reagents and plastic ware were obtained from commercial sources. 127 
 128 
Isolation of Mitochondria from S. cerevisiae 129 
Yeast cells were grown in Yeast Peptone Dextrose (YPD) at 30°C up to 130 
OD600nm=1,2.Mitochondria were isolated as detailed in the Supplemental Information section. 131 
Briefly, spheroplasts have been first  generated by the enzymatic digestion of the cells wall by 132 
Zymolase 20T (Euromedex) and further broken by homogenization  in a glass-Teflon potter. 133 
After the removal of cell debris and nuclei by centrifugation (1,500×g, 5 min at 4°C), 134 
mitochondria were recovered from the supernatant by additional centrifugations at 12,000×g 135 
for 15 min at 4°C, to give a final concentration of 5 mg/ ml. Mitochondrial fraction was 136 
treated by 10 strokes in a glass-Teflon potter and loaded onto a four-step sucrose gradient, 137 
from which purified mitochondria were recovered from the 60 %/ 32 % interface. 138 
 139 
In solution protein digestion  140 
 141 
10µg of protein were diluted in 75µL ammonium bicarbonate buffer (50mM) and incubated 142 
with 5µL DTT 0.1M for protein denaturation (10min, 95°C). After cooling down, 10µL IAA 143 
0.1M were added and the samples were incubated for 20min at room temperature in the dark 144 
to allow alkylation of reduced cysteine residues. For protein digestion, 500ng (1:20) trypsin 145 
(Promega, V5111) was added and sample was incubated overnight at room temperature. For 146 
nano-LC/MSMS analysis, 3µg of the clear supernatant were transferred into glass inserts and 147 
evaporated to dryness using a miVac DNA concentrator (Genevac, NY, USA). The sample 148 
waseither reconstituted in 15µL formic acid (0.1% v/v) for nanoLC-MS/MS analyses or in 149 
ammonium acetate 50 mM (pH 4.0) for CESI-MS/MS analyses.  150 
 151 
NanoLiquid Chromatography  152 
Samples were transferred into glass inserts, compatible with the LC autosampler system (ultra 153 
nanoLC-2D plus, Eksigent, UK). Five microliters of each sample were loaded on a 154 
nanoFlexcHiP module consisting of a Trap-and-elute jumper (fluidics configuration design), a 155 
ChromXP-C18 trap cHiP column (0.5cm x 200µm i.d., 3µm, 120Å, Eksigent) and a 156 
ChromXP-C18 analytical cHiP column (15cm x 75µm i.d., 3µm, 120Å, Eksigent). The 157 
separation method consisted in a 60 min run at a flow rate of 300 nL/min using a gradient of 158 
two solvents: A (99.9% water: 0.1% formic acid) and B (99.9% acetonitrile: 0.1% formic 159 
acid). After a 10 min step to trap the peptides on the pre-concentration column at 20µL/min, 160 
they were eluted from the analytical column as follows: 0-35 min, 5-40% B; 35-36 min, 40-161 
80% B; 36-40 min, 80% B; 40-41 min, 80-5% B; 41-60 min, 5% B.  162 
 163 
Capillary Electrophoresis  164 
 165 
The CE experiments were performed with a CESI8000 capillary electrophoresis system from 166 
Sciex separations (Brea, CA) equipped with a temperature controlled autosampler and a 167 
power supply able to deliver up to 30 kV. Bare fused-silica capillaries (total length 91 cm; 168 
30μm i.d.) with characteristic porous tip on its final 3 cm supplied by Sciex separation 169 
allowed electric contact between both electrodes of the CE system. New capillaries were 170 
flushed at 75 psi (5.17 bar) for 10min with methanol, then 10min with 0.1M sodium 171 
hydroxide, followed 10min with 0.1M hydrochloric acid and water for 20min. Finally, the 172 
capillary was flushed 10min at 75 psi with BGE which was acetic acid 10%. Hydrodynamic 173 
injection (410 mbar for 1min) corresponding to a total volume of 55 nL of sample injected 174 
was used. Separations were performed using an electric field of +219.8 V/cm-1. 175 
 176 
Mass spectrometry  177 
The LC and CESI systems were coupled to a 5600Triple TOFTM system (AB Sciex, CA, 178 
USA) with nanospray source operating in positive ESI mode. Interchangeability of the LC 179 
and CESI systems is easy and takes only 20 min. The mass spectrometer was operated in the 180 
IDA mode (Information-Dependent Acquisition) and was externally calibrated each 6 hours 181 
with 25fmol of an E.coli Beta-galactosidase digest. This standard also allowed to regularly 182 
check the performances and reproducibility of the mass spectrometer. For the nanoLC-183 
MS/MS, the following ESI source parameters were used: ion spray voltage, 2.3 kV; ion 184 
source heater, 150 °C; curtain gas, 22 psi and ion source gas 1,5 psi. While for the CESI-185 
MS/MS and due to the nanospray properties, the ESI source parameters were: ion spray 186 
voltage, 1.75 kV (1.0 to 4.0 mm between the MS inlet and capillary tip); ion source heater, 75 187 
°C; curtain gas, 5 psi (flow rate < 100 nL/min) and ion source gas 1, 0 psi. The MS survey 188 
scan was acquired over a 400-1250 m/z mass range with a 250ms accumulation time; whereas 189 
the product ion experiments mass range was extended to 100-2000 m/z with a 60ms 190 
accumulation time. The duty cycle time was therefore maintained below 2s with up to 30 191 
precursor ions selected on the MS survey scan to undergo CID fragmentation (Collision 192 
Induced Dissociation), while respecting the following criteria: intensity greater than 150 193 
counts per second, charge state between 2+ and 5+, not present in the dynamic exclusion list, 194 
exclusion after a period of 15s and 2 consecutive MS/MS spectra, and use of a rolling 195 
collision energy. Data were acquired with Analyst 1.6 software (AB Sciex) and the resulting 196 
.wiff files were primarily evaluated with PeakView 1.2 software (AB Sciex). 197 
 198 
Data Analysis 199 
For protein identification, the MS/MS raw data files were first converted to mascot generic 200 
format (mgf) using the executable MS-DataConverter.exe (AB Sciex). MS data processing 201 
was then performed with Proteinscape software (version 3.1, Bruker Daltonics). We used the 202 
Mascot algorithm (v2.2, Matrix Science, UK) for database searching, configured with the 203 
following parameters: (a) database: Swiss-Prot with Baker’s Yeast taxonomy (version 2013-204 
01-09, 18860 sequences), (b) enzyme: Trypsin/P, (c) maximum missed cleavages: 3, (d) 205 
variable modifications: acetylation (Protein N-term), oxidation (Met), carbamidomethylation 206 
(Cys), (e) peptide mass tolerance: 30 ppm, (f) MS/MS tolerance: 0.5 Da, (g) Instrument: ESI-207 
Quad-TOF. To evaluate the false-positive rate of each analysis, we generated a reversed yeast 208 
database using a Pearl script (makeDecoyDB.pl, Bruker): the fusion of this decoy database 209 
with the original forward yeast database allowed Proteinscape to validate the data at 210 
FDR<1%. Moreover, redundancy was taken into account by Proteinscape (grouping of 211 
proteins sharing exactly the same set of peptides) and a manual inspection of the MS/MS 212 
fragmentation spectra was done for proteins identified with 1 peptide and a Mascot Score 213 
below 50. The same MS/MS raw data files were then submitted to a second database search 214 
algorithm, (Paragon, AB Sciex) with the following parameters: (a) database: the same Baker’s 215 
Yeast taxonomy as described previously for Mascot, (b) enzyme: Trypsin, (c) Cys alkylation: 216 
Iodoacetamide, (d) ID focus: biological modifications, (e) search effort: thourough ID, (f) 217 
confidence p-value: 0.05, (g) Instrument: Triple-TOF 5600. 218 
To facilitate the biological interpretation of the protein identification lists, the PANTHER 219 
classification system (http://pantherdb.org/) has been applied in a first instance on both 220 
nanoLC-MS/MS and CESI-MS/MS datasets. A second classification system named iLoc-Euk 221 
(http://www.jci-bioinfo.cn/iLoc-Euk) was then used to assess the subcellular localization of 222 
each identified protein. Combining both prediction softwares during the final data mining step 223 
allowed to strengthen the confidence related to each protein biological significance. 224 
Parameters used for both systems are detailed in the Supplemental Information section. 225 
 226 
Results  227 
Peptide metrics to highlight CESI-MS/MS and nanoLC-MS/MS approaches. 228 
Consecutively to the development of the ESI ionization source and its application to 229 
study biological analytes in MS, technical developments have been achieved in order to 230 
perform a separation prior to the MS analysis. Performing a separation before the ionization 231 
process allows to analyze samples with an increased complexity and tends to enhance the 232 
sensitivity of the signal by limiting the competition effect during ESI ionization 36. Interfaces 233 
allowing CE-MS hyphenation were therefore developed as CE is well suited for the separation 234 
of biological analytes such as peptides or proteins while providing high efficiency separation 235 
due to the absence of stationary phase. In this work, a recently introduced sheathless CE-MS 236 
interface (CESI) has been used. A detailed description of the system has been provided in the 237 
literature by Haselberg et al.13. Recently, following the improvement of shotgun proteomics 238 
with recent mass spectrometer, different research groups have described shotgun proteomic 239 
experiments performed by sheathless CE-MS using commercially available or custom-made 240 
interfaces 37,38. One of the major goals of this study was in a first instance to identify a great 241 
number of proteins from a relatively low amount of yeast mitochondrial extract. For that 242 
purpose, we used either the state-of-art shotgun proteomic configuration with a RP-nanoLC-243 
MS/MS interface, or the promising CESI-MS/MS interface 39-41. ESI parameters for NanoLC 244 
and CESI systems are defined in order to be compatible with nanoESI flowrate (300 nL/min 245 
for nanoLC and <100 nL/min for CESI) and totally comparable in terms of performance (See 246 
Experimental section). 100ng of material, a quantity which can be typically obtained after a 247 
sub-cellular fractionation process on a wide variety of organisms, were injected on both 248 
couplings. When considering studies published during the last 5 years, we can notice that 249 
starting sample amounts ranging from 1ng to 400ng were often considered, with an average at 250 
100ng  (Supplemental Table S1). Moreover, as stated by Sun et al in their review published in 251 
2014 (Sun et al., 2014), the vast majority of proteomic studies using a nanoLC-MS/MS 252 
approach are typically starting with biological samples quantities in the milligram or 253 
microgram range. That’s why CESI-MS/MS approach appears as a good alternative when the 254 
starting material is limited and falling into the midnanogram range.  255 
To obtain a simple picture from the two complex MS datasets generated, heat maps were 256 
reconstructed using PeakView software. The mass/charge ratio of the peptides (Da) is plotted 257 
against the LC elution time or the CZE migration time (Figures 1-A and 1-B). A nanoLC-258 
MS/MS heat map, like the one we obtained for the injection of 100ng of a yeast mitochondrial 259 
extract, is generally characterized by a wide cloud of dots, each of them representing a unique 260 
MS/MS spectrum related to the fragmentation of a given precursor ion (Figure 1-A). This 261 
cloud of dots means that LC conditions are regularly eluting peptides from the reverse-phase 262 
column, without introducing any additional phenomenon except the fact that hydrophobic 263 
peptides will elute latter than hydrophilic peptides. In contrast, the heat map obtained with the 264 
CESI-MS/MS interface displays a very different picture: distinct and successive lines or 265 
“strikes” of analyzed peptides can be drawn on the graph (Figure 1-B). This pattern can be 266 
explained by the CZE migration process itself as it depends not only on the charge in solution 267 
of the analytes but also on their mass-to-charge ratios.  268 
 269 
Figure 1. MS data obtained on 100ng of yeast mitochondrial extract. (A) NanoLC-MS/MS 270 
injection: heat map, where the mass-to-charge ratio of the peptides (Da) is plotted against the 271 
LC elution time (min). Each blue dot is related to a single MS/MS fragmentation spectrum. 272 
(B) CESI-MS/MS injection: heat map, where the mass-to-charge ratio of the peptides (Da) is 273 
plotted against the CE migration time (min). (C) Number of proteins and peptides identified in 274 
either the nanoLC-MS/MS (red) or the CESI-MS/MS (blue) injection. 275 
A yeast UniProtKB database was used to identify peptides and proteins and a maximum 276 
false-positive rate of 1% was applied to validate both MS datasets. As shown in the Venn 277 
diagram (Figure 1-C), 222 proteins were identified with either CESI-MS/MS or nanoLC-278 
MS/MS analysis. In addition, 78 proteins were only identified by CESI-MS/MS while 49 279 
other proteins were only identified by nanoLC-MS/MS. Proteins identified by both 280 
approaches represent the majority of the proteins identified in the two nanoLC-MSMS and 281 
CESI-MSMS analyses, 82% and 74% respectively. This complementarity observed between 282 
both couplings also agrees with previous reports 37,42. Interestingly, CESI-MS/MS coupling 283 
allowed to identify 3 times more additional peptides compared to the classical nanoLC-284 
MS/MS configuration (412 versus 1201 peptides), providing already a positive insight into 285 
the power of CESI-MS/MS for obtaining good sequence coverages. It must be emphasized 286 
that the number of identified proteins for each approach was obtained with a single injection 287 
and is not the sum of multiple technical repeats. Among the 222 proteins identified commonly 288 
by both CESI-MS/MS and nanoLC-MS/MS, half of them are characterized by shared 289 
peptides, as well as additional peptides identified specifically by CE or LC (scenario #2 = 290 
EQUIV in Supplemental Figure S1): this scenario leads all the same to an equivalent result 291 
which is the identification of a given protein in the biological sample.  Interestingly, this 292 
observation  means that the two orthogonal methods of separation used in this study were 293 
identifying peptides bearing the same biophysical properties (564 common peptides, 294 
representing 26% of the whole dataset) but that there are more additional peptides only 295 
identified by the CE approach (1201) compared to the LC approach  (412). This observation 296 
is also concordant with the fact that 41 proteins identified by LC are also identified by CE but 297 
with a higher number of peptides (scenario #3 = CE+ in Supplemental Figure S1). To note, 298 
25% of the 222 common proteins are characterized by a completely different set of peptides 299 
(scenario #5 = DIFF in Supplemental Figure S1). This latest observation is nicely showing the 300 
usefulness of combining orthogonal separative methods before the mass spectrometry 301 
analysis. 302 
 303 
Figure 2. Comparison of peptides molecular weight (A), mass-to-charge (m/z) ratio (B), pI 304 
(C) and Mascot score (D) by means of CESI-MS/MS (red) and nanoLC-MS/MS (blue). Data 305 
are obtained from the analysis of 100ng of a mitochondrial yeast tryptic digest on both types 306 
of coupling.  307 
 308 
To evaluate each type of coupling for identification of peptides bearing specific biophysical 309 
properties, we next represented the percentage of observed peptides obtained by each 310 
separation against their molecular weights (MW, Figure 2-A), mass-to-charge ratios (m/z, 311 
Figure 2-B), isoelectric points (pI, Figure 2-C) and Mascot scores (Figure 2-D). The most 312 
evident trend arises from the molecular weight distribution pattern: very large peptides were 313 
mostly detected with CESI-MS/MS rather than nanoLC-MS/MS. Indeed, only 10 peptides 314 
observed by nanoLC-MS/MS have a molecular weight above 2800 Da, whereas this number 315 
is reaching 466 peptides in the CESI-MS/MS injection: this might be explained by their 316 
irreversible adsorption to either the preconcentration or the chromatographic column, or the 317 
difficulty to correctly elute these large peptides. The detection of large peptides by CESI-318 
MS/MS is also a phenomenon visible in the medium mass range: the apexes of both MW 319 
distributions are separated by 400 Da, with the CESI-MS/MS data displaying the highest apex 320 
and the wider distribution. For example, in the medium mass range from 751 to 1250 Da, 52% 321 
of peptides were detected with CESI-MS/MS, versus 10% with nanoLC-MS/MS. On the 322 
contrary, in the low mass range from 400 to 750 Da, 90% of peptides were detected with 323 
nanoLC-MS/MS, versus 48% with CESI-MS/MS (Figure 2-A). The same results are obtained 324 
when we look at mass-to-charge ratios of the peptides, which are more widely used instead of 325 
the global molecular weight (Figure 2-B). In this study, no enrichment towards low MW 326 
peptides was observed in the CESI-MS/MS dataset. Interestingly, some other groups also 327 
highlighted, on another biological system, the fact that CESI-MS/MS allows to elute peptides 328 
of low MW 18. These peptides are often composed of only a few amino acids, thereby giving 329 
them a hydrophilic property. This type of peptides is also more difficult to observe with 330 
nanoLC-MS/MS, as they are weakly bound or even unretained on reverse-phase stationary 331 
phases.  332 
Another important feature to monitor is the pI value from the identified peptides. Here, we 333 
used the « Compute MW/pI » tool from Expasy to obtain the isoelectric point values for all 334 
the observed peptides, resulting in a bi-modal distribution with unevenly distributed peptidic 335 
pI values across the pH scale, with a gap at pH 7-8, and the majority of peptides clustering at 336 
pH 4-6 (Figure 2-C). It can be noted that the pI distribution obtained on this S. cerevisiae 337 
mitochondrial extract is in agreement with previously published data like theoretical 2D-gels 338 
reconstructed by Knight et al. 43 on a wide variety of organisms including the total yeast 339 
proteome as well as sub-cellular yeast fractions. Results on pI distribution obtained in this 340 
study on a mitochondrial yeast extract are relatively similar. Slight differences can be 341 
observed all the same for the extreme pI values, especially extremely basic peptides (pI>10) 342 
or peptides with more acidic property (pI<4), as already shown by other research groups 37. 343 
This phenomenon is potentially a result of the decreased ion suppression at very low flow 344 
rates and could be of particular interest for phosphopeptides detection without any enrichment 345 
techniques 42.   346 
 347 
Figure 3. Effect on the global protein coverage when comparing the CESI-MS/MS (blue) and 348 
the nanoLC-MS/MS (red) datasets.  (A) Proteins are ranked according to the total number of 349 
MS/MS spectra matching to each sequence (log scale) and 5 proteins, distributed all along the 350 
dynamic range, were further investigated. (B) Comparison of the sequence coverage from the 351 
5 previously chosen proteins: shared and specific peptides are indicated in each Venn 352 
diagram, as well as the total sequence coverage increase (in %). (C) Boxplot showing the 353 
sequence coverage distributions for both datasets when considering all the identified proteins. 354 
 355 
Discussions 356 
Increasing sequence coverage versus spectrum quality.  357 
Maximal sequence coverage is recommended to increase protein identification 358 
confidence but coverage should not be won to the detriment of the spectral quality. As this 359 
parameter can be evaluated with the Mascot Score obtained for each spectrum, we next 360 
represented the Mascot Score distributions obtained on the CESI-MS/MS and nanoLC-361 
MS/MS injections of 100ng mitochondrial extract (Figure 2-D). Interestingly, there are more 362 
peptides with a score lower than 61 identified by the nanoLC-MS/MS approach. The CESI-363 
MS/MS coupling provides more peptides with a score upper than 61: these high quality 364 
MS/MS spectra are representing 39.8% of the whole CESI dataset and 27.7% of the whole LC 365 
dataset. As for the median Mascot Score, it shows a slight increase from 48.3 to 52.8, for the 366 
LC or CE separations respectively (Supplemental Figure S4-A). A wider distribution is also 367 
observed for the CESI-MS/MS dataset, and this observation is more noticeable when 368 
considering the sub-set of peptides composed of the LC- and CE-specific features 369 
(Supplemental Figure S4-A). This Mascot Scores comparison is thus reflecting the overall 370 
good spectral quality obtained for both types of coupling. 371 
As Wang et al 39 did previously while using the Sequest XCorr, we decided to use the 372 
Mascot score, which is probably the most widely-used database search algorithm by the 373 
proteomic community. Moreover, to strengthen these data, we also used a second dataset 374 
search algorithm, namely Paragon (ProteinPilot, AB Sciex): relevant observations can thus be 375 
conducted by combining 2 different algorithms, as recommended by proteomics guidelines. 376 
Paragon algorithm returns the percentage of MS/MS spectra above a given confidence 377 
threshold: we can observe that there are always more fragmentation spectra above this 378 
threshold in the CESI-MS/MS dataset compared to the nanoLC-MS/MS dataset, whether the 379 
confidence threshold is set (up to 99%, Supplemental Figure S4-C). 380 
 381 
Figure 4. Venn diagrams indicating the distribution of mitochondrial proteins identified with 382 
Panther and iLoc-Euk databases using nanoLC-MS/MS and CESI-MS/MS approaches. 383 
Distribution of proteins between mitochondrion and other sub-cellular compartments using 384 
the nanoLC-MS/MS dataset (A) or the CESI-MS/MS dataset (B). (C) displays the overlap 385 
between the global protein dataset and the mitochondrial proteins using the two approaches. 386 
 387 
There is a particular interest in the development of alternative technologies that could 388 
improve sequence coverages, to secure more confident identifications, especially for low-389 
abundant proteins often characterized by a single or a few peptides. To study the usefulness of 390 
CESI-MS/MS to increase sequence coverage, we first ranked the identified proteins according 391 
to the total number of MS/MS fragmentation spectra matching to each of them. While plotting 392 
the resulting Spectral Count value as a function of the protein rank, we were able to select a 393 
panel of 5 different proteins which were homogeneously distributed all along the dynamic 394 
range from both datasets (Figure 3-A). When specifically inspecting the peptides distribution 395 
from this sub-set of proteins, we can observe that sequence coverage is indeed increased in 396 
the CESI-MS/MS analysis compared to the nanoLC-MS/MS analysis (Figure 3-B). While the 397 
effect on the sequence coverage increase is drastically observable on high-abundant proteins 398 
like PMA1, ODPA and ADH1, a more reasonable impact is observed for mid- and low-399 
abundant proteins like COX4 and ISD11. We further considered the whole set of proteins and 400 
thus represented the distribution of the global protein sequence coverage depending on the 401 
type of coupling (Figure 3-C) and observed the same trend. The example of the yeast plasma 402 
membrane ATPase PMA1 can illustrate the sequence coverage increase that was observed in 403 
this yeast mitochondrial dataset (Supplemental Figure S3-A). 24.8% sequence coverage was 404 
reported for PMA1 by nanoLC-MS/MS with 21 identified peptides, while sequence coverage 405 
from CESI-MSMS was 43.5% with 45 identified peptides (Supplemental Figure S3-A). 406 
Interestingly, the 21 peptides identified by nanoLC-MS/MS were all identified by CESI-407 
MS/MS (annotated in red on Supplemental Figure S3-A). Moreover, among the additional 24 408 
peptides identified only by CESI-MS/MS, it can be noted that 7 of them have a large mass-to-409 
charge ratio (m/z > 1000, highlighted in yellow on Supplemental Figure S3-A): these 5 unique 410 
peptides at [175-215], [216-252], [386-414], [482-508] and [584-615] are already 411 
representing 17.7% of the whole PMA1 sequence (17678 Da over 99619 Da for the full 412 
length protein). For the 21 peptides identified by both separative techniques, 17 of them have 413 
a CE Mascot Score higher than the corresponding LC Mascot Score (highlighted in grey in 414 
Supplemental Figure S3-A). To note, the MS/MS fragmentation spectra of the 5 largest 415 
peptides are of good quality as suggested by their average Mascot Score (84.6, Supplemental 416 
Figure S4-B) and have acidic pI values (average pI = 4.25).  Such very large peptides are 417 
heavily contributing to increase the total sequence coverage. Interestingly, as suggested by 418 
other works, CESI-MS/MS is also able to identify small peptides that aren't by nanoLC-419 
MS/MS. For example, the C-terminal part from PMA1 was covered in the CESI-MS/MS 420 
analysis with the doubly-charged peptide [910-918] being sequenced at m/z=529.7611, as 421 
well as 4 other small peptides (highlighted in grey on Supplemental Figure S3-A, peptides 422 
[272-278], [380-385], [429-435] and [436-442]). Similarly, when investigating the 4 other 423 
proteins distributed all along the dynamic range from the yeast mitochondrial sample (Figure 424 
3-A), the same sequence coverage increase is observed (Supplemental Figures S3-B to S3-E). 425 
S.cerevisiae mitochondrial proteins identification 426 
Biological interpretation of the data is of paramount importance for assessing the 427 
strength of mass spectrometric and proteomic results, and validation using orthogonal 428 
techniques is often requested to publish MS data. In this study, a focus was established on the 429 
yeast mitochondrial sub-proteome. Indeed, the determination of a protein's localization is 430 
useful for biologists because it is linked to its cellular function 44. It can also pinpoint some 431 
molecular functions to specific organelles 45. Thus, in order to perform a high-throughput 432 
cellular localization analysis of all identified proteins, two protein classification systems were 433 
used: PANTHER 46 and iLoc-Euk 47. With the nanoLC-MS/MS approach (Figure 4-A), 55.3% 434 
of proteins have been identified and clustered as mitochondrial proteins while 53% of them 435 
were classified as mitochondrial proteins in the CESI-MS/MS dataset (Figure 4-B). In Figure 436 
4-B, we can see that 127 mitochondrial proteins overlap between the two methods. Among 437 
the 349 proteins identified with both methods, 52.1% are known mitochondrial proteins, while 438 
the rest of them have been reported to be located into other subcellular compartments.  439 
 440 
Figure 5. How is it possible to distinguish 2 protein isoforms using discriminant peptides and 441 
an increased sequence coverage: ENO1 and ENO2 proteins as an example.  (A) Comparison 442 
of the sequence coverage for each isoform: shared and specific peptides are indicated in the 443 
Venn diagrams, as well as the total sequence coverage increase (in %). (B) BLAST-P 444 
alignment between both ENO isoforms. (C) Detailed sequence coverage on both isoforms 445 
obtained by either the CESI-MS/MS or the nanoLC-MS/MS analysis: identified amino acids 446 
are shown with a red label, whereas the grey box below the corresponding peptide is 447 
indicating the MS/MS spectrum quality (a red box is attributed under each amino acid if it 448 
was seen with either a b- or a y-ion, represented in the upper and lower section of the grey 449 
box respectively). Proteotypic peptides allowing the distinction between both isoforms in each 450 
dataset are indicated with purple boxes.  (D)  Focus on 2 proteotypic peptides matching on 451 
ENO1 and ENO2 sequences:  a difference of 2 amino acids in the composition of a peptide is 452 
easily distinguishable when inspecting the MS/MS fragmentation spectra. 453 
 454 
Identifying 100% of the proteins of an entire organelle from only one proteomic 455 
experiment remains a big challenge. Some proteins may escape from detection because of the 456 
technology used to separate the analytes upstream from the mass spectrometer itself: this 457 
effect is often emphasized when analytes are of extreme biophysical properties (like 458 
hydrophilic or very small peptides). To evaluate the pertinence of our proteomic dataset 459 
compared to the set of mitochondrial proteins already seen by coworkers, we selected 16 460 
studies dealing with yeast mitochondria published between 1997 and 2014 23,33,35,48-60. 461 
Accession numbers were homogeneously converted and aligned: many proteins thus appeared 462 
to be well-characterized by the community as seen by the frequency of observation, whereas a 463 
sub-set of 23 proteins was only identified in our study. Among them, an intriguing protein 464 
named ENO1 was further investigated because it was only identified in the CESI-MS/MS 465 
dataset with 41 MS/MS spectra. Enolases are essential glycolytic enzymes that catalyse the 466 
interconversion of 2-phosphoglycerate to phosphoenolpyruvate. They are present under two 467 
isoforms, named A and B,  in Saccharmomyces ceravisiae 61. It is very important to describe a 468 
biological sample as exhaustively as possible, thus including isoforms characterization by 469 
mass spectrometry: this is possible by the identification of discriminant proteotypic peptides 470 
matching on each isoform sequence. Figure 5-A displays the number of distinct peptides 471 
identified for each enolase isoform using either the CE or LC approach: isoform B (ENO2) 472 
was covered by a higher number of peptides even if the 2 proteins have slightly the same 473 
molecular weight. 95% of identity is achieved on 495 residues when aligning the two protein 474 
sequences with Blast-P (98% of positive matches, Figure 5-B), rendering these isoforms 475 
difficult to distinguish. While investigating the detailed sequences of the matching peptides 476 
using the Sequence viewer from Proteinscape software, we can conclude that ENO1 (isoform 477 
A) was not validated in the LC dataset because its 6 peptides were an exact sub-set from the 8 478 
peptides matching on the ENO2 sequence (ENO1 is a so-called sub-set protein). Whereas in 479 
the CE dataset, 2 proteotypic peptides were identified for the ENO1 sequence and 8 480 
proteotypic peptides were specifically matching on the ENO2 sequence (Figure 5-C). To note, 481 
MS/MS fragmentation spectra of good quality were obtained for these proteotypic peptides 482 
(Figure 5-D) and allow to distinguish two peptide sequences with close amino acids 483 
composition. Likewise, the CE results also allow to observe two yeast glyceraldehyde-3-484 
phosphate dehydrogenase isoforms (G3P2 and G3P3). The CESI-MS/MS injection was 485 
finally the only analysis in which we were able to distinguish the two yeast enolase isoforms 486 
with a good confidence. Moreover, we also clustered the protein identifications in terms of 487 
protein families, to see if specific families were identified by one of the two approaches. The 488 
CESI-MS/MS dataset was seen to increase the number of members from four protein families, 489 
related to mitochondrial protein import (TIM), ergosterol biosynthetic process (ERG), 490 
mitochondrial electron transport (QCR) and ATP synthesis (ATP) (Supplemental Figure S5-491 
A). Proteins belonging to the TIM, QCR and ATP families are located in the mitochondrial 492 
inner membrane whereas proteins from the QCR family are related to cell membrane, where 493 
sterols are targeted. Given the importance of membrane proteins in various cellular processes, 494 
as well as their roles in diseases, it is important that this class of proteins be better studied. 495 
But identifying and characterizing proteins embedded in membranes still remains a challenge 496 
in proteomics due to difficulties during the solubilization step. With the complementary 497 
identifications obtained by combining orthogonal separative techniques, a better chance is 498 
given to membrane proteins and therefore hydrophobic related peptides to be detected and 499 
identified by MS. Exploring the 2 datasets with the same type of clusterization also allows to 500 
identify protein families that are covered by CESI-MS/MS and nanoLC-MS/MS in an 501 
equivalent manner, with members specifically identified by only 1 of the 2 techniques: this is 502 
the case for the 40S and 60S ribosomal proteins family (Supplemental Figure S5-B). 503 
 504 
 505 
Conclusion  506 
To compare correctly datasets and to assess an eventual complementarity between CESI-507 
MS/MS and nanoLC-MS/MS techniques, we used a large panel of peptide properties: MW, 508 
m/z, pI, Mascot Score, % peptides per protein and % sequence coverage. Based on the results 509 
presented in this study, when a low quantity of yeast mitochondrial extract is analyzed, CESI-510 
MS/MS enables the identification of more peptides than nanoLC-MS/MS, and thus a higher 511 
protein sequence coverage. This improvement is consistent with the actual proteomics 512 
guidelines, as drastic procedures must be employed to assess the maximum of confidency on 513 
protein identification. Moreover, one of the more visible trend is concerning the peptide 514 
metric related to the MW of the observed peptides: indeed, more peptides having a molecular 515 
weight above 2000 Da have been detected by CESI-MS/MS, whereas only some of them 516 
falling into the same mass range have been identified by nanoLC-MS/MS. In parallel to the 517 
increase of the number of large peptides, the peptide charaterizing metric concerning the pI 518 
distribution was also investigated: our results indicate that more extreme pI values (pI<4 and 519 
pI>10) are covered by CESI-MS/MS rather than nanoLC-MS/MS. These observations are 520 
leaving the door open for the detection of peptides carrying particular biophysical properties, 521 
like phosphopeptides, without the need of enrichment techniques. In this study, the evaluation 522 
of the overall spectral quality from the CESI-MS/MS and nanoLC-MS/MS data was 523 
performed by considering the Mascot score distributions and the Paragon confidence 524 
thresholds. Results are suggesting that increasing the sequence coverage has no detrimental 525 
impact on spectrum quality.  526 
A challenging area of research in proteomics concerns isoforms charaterization. There are 527 
several explanations for protein isoforms, among which multiple gene copies (allele 528 
variation), alternative splicing, post-translational modifications (PTM) or degradation 529 
products. In this study, we demonstrated that the 2 yeast enolase isoenzymes were both 530 
charaterized in the CESI-MS/MS dataset. The observation of discriminant proteotypic 531 
peptides is facilitated when a high number of precursors with high-quality MS/MS spectra are 532 
generated. Traditional approaches are combining different proteolytic enzymes or are 533 
benefiting from the integration of bottum-up proteomics with top-down and middle-down 534 
approaches. A combination of orthogonal separative techniques, coupled online to the mass 535 
spectrometer, also appears to be a good alternative to decipher a complex proteome. 536 
The evaluation of both techniques using a large panel of peptide metrics allow us to say 537 
that they possess complementary properties for peptide and protein identification in 538 
mitochondria isolated from cultured S. cerevisiae. Moreover, the power of integrating two 539 
orthogonal separative technologies and two protein classification systems offers new 540 
promising opportunities to researchers working in the mitochondrial field of yeasts and other 541 
organisms, and more broadly in subcellular proteomics. 542 
 543 
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